Documente Academic
Documente Profesional
Documente Cultură
Formula Uses/properties
STA001
Data
http://www.cdc.gov/hicpac/Disinfection_Sterilization/3_2contaminatedDevices.h
tml
STA001
Efficacy of various disinfectants against SARS coronavirus
Journal of Hospital Infection, Volume 61, Issue 2, Pages 107-111
H.F. Rabenau, G. Kampf, J. Cinatl, H.W. Doerr
The recent severe acute respiratory syndrome (SARS) epidemic in Asia and Northern America led to
broad use of various types of disinfectant in order to control the public spread of the highly contagious
virus. However, only limited data were available to demonstrate their efficacy against SARS coronavirus
(SARS-CoV). We therefore investigated eight disinfectants for their activity against SARS-CoV according
to prEN 14476. Four hand rubs were tested at 30s (Sterillium, based on 45% iso-propanol, 30% n-
propanol and 0.2% mecetronium etilsulphate; Sterillium Rub, based on 80% ethanol; Sterillium Gel,
based on 85% ethanol; Sterillium Virugard, based on 95% ethanol). Three surface disinfectants were
investigated at 0.5% for 30min and 60min (Mikrobac forte, based on benzalkonium chloride and
laurylamine; Kohrsolin FF, based on benzalkonium chloride, glutaraldehyde and didecyldimonium
chloride; Dismozon pur, based on magnesium monoperphthalate), and one instrument disinfectant was
investigated at 4% for 15min, 3% for 30min and 2% for 60min [Korsolex basic, based on glutaraldehyde
and (ethylenedioxy)dimethanol]. Three types of organic load were used: 0.3% albumin, 10% fetal calf
serum, and 0.3% albumin with 0.3% sheep erythrocytes. Virus titres were determined by a quantitative
test (endpoint titration) in 96-well microtitre plates. With all tested preparations, SARS-CoV was
inactivated to below the limit of detection (reduction factor mostly 4), regardless of the type of organic
load. In summary, SARS-CoV can be inactivated quite easily with many commonly used disinfectants
STA001
In suspension, HCoV-229E gradually lost its infectivity completely while SARS-CoV retained its infectivity
for up to 9 days; in the dried state, survival times were 24 h versus 6 days. Thermal inactivation at 56C
was highly effective in the absence of protein, reducing the virus titre to below detectability; however,
the addition of 20% protein exerted a protective effect resulting in residual infectivity. If protein-
containing solutions are to be inactivated, heat treatment at 60C for at least 30 min must be used.
Different fixation procedures, e.g. for the preparation of immunofluorescence slides, as well as chemical
means of virus inactivation commonly used in hospital and laboratory settings were generally found to
be effective. Our investigations confirm that it is possible to care for SARS patients and to conduct
laboratory scientific studies on SARS-CoV safely. Nevertheless, the agent s tenacity is considerably
higher than that of HCoV-229E, and should SARS re-emerge, increased efforts need to be devoted to
questions of environmental hygiene.
STA001